great work OSL!!! achieving a great milstone into US market. OncoSil Medical receives FDA Breakthrough Device Designation for its device for the treatment of unresectable locally advanced pancreatic cancer in combination with systemic chemotherapy.
next step is now to work closely with the FDA to ensure that the proposed premarket approval PMA
great work OSL!!! achieving a great milstone into US market....
Add to My Watchlist
What is My Watchlist?
 (20min delay)
|
|||||
|
Last
$1.20 |
Change
0.040(3.45%) |
Mkt cap ! $17.06M | |||
| Open | High | Low | Value | Volume |
| $1.19 | $1.20 | $1.15 | $62.83K | 53.53K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 146 | $1.23 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $1.25 | 2418 | 1 |
View Market Depth
| Last trade - 15.55pm 30/06/2025 (20 minute delay) ? |
| OSL (ASX) Chart |